MaRS Discovery District

Sibli Closes $4.5M Seed Round Led by Staircase Ventures

Retrieved on: 
Tuesday, February 13, 2024
Algorithm, MaRS Discovery District, AI, Generative, Growth, Entrepreneurship, ARR, Attention, Ideation, Automation, EBay, IAF, IP, Research, Cryptocurrency

TORONTO, Feb. 13, 2024 /PRNewswire-PRWeb/ -- Sibli (formerly Responsibi), a company transforming the investment research process using AI, announced today it has closed a $4.5M US Seed round led by Staircase Ventures, a firm overseen by high-tech pioneer Janet Bannister (eBay, Kijiji). The deal included participation by The Group Ventures, Burst Capital, MaRS IAF, and private investors. The company also announced a rebrand to better align with its broader perspectives and vision.

Key Points: 
  • Sibli (formerly Responsibi), a company transforming the investment research process using AI, announced today it has closed a $4.5M US Seed round led by Staircase Ventures, a firm overseen by high-tech pioneer Janet Bannister (eBay, Kijiji).
  • TORONTO, Feb. 13, 2024 /PRNewswire-PRWeb/ -- Sibli (formerly Responsibi), a company transforming the investment research process using AI, announced today it has closed a $4.5M US Seed round led by Staircase Ventures, a firm overseen by high-tech pioneer Janet Bannister (eBay, Kijiji).
  • The deal included participation by The Group Ventures, Burst Capital, MaRS IAF, and private investors.
  • Janet Bannister, Founder & Managing Partner at Staircase Ventures said, "We are bullish about the potential of AI to transform many sectors, including asset management and finance.

Quthero Accepted into Prestigious MaRS-adMare Tx Accelerator

Retrieved on: 
Thursday, December 14, 2023
Corporation, Accelerator, Heart, Senior, Therapy, Scar, Regeneration, Patient, Ecosystem, Partnership, ADMAR, Corporate development, Red, Growth, Doctor of Philosophy, Dermatology, Environment, Pharmaceutical industry, MaRS Discovery District

TORONTO, Dec. 14, 2023 /PRNewswire/ -- Quthero, a biotech company with a unique, patented Q-peptide platform technology was accepted into the MaRS – adMare Therapeutics (Tx) Accelerator which provides a distinctive ecosystem for the development of novel therapeutics in Ontario and Canada.

Key Points: 
  • TORONTO, Dec. 14, 2023 /PRNewswire/ -- Quthero, a biotech company with a unique, patented Q-peptide platform technology was accepted into the MaRS – adMare Therapeutics (Tx) Accelerator which provides a distinctive ecosystem for the development of novel therapeutics in Ontario and Canada.
  • "The partnership between MaRS and adMare presents Quthero with a unique opportunity to access the most experienced players in the development of new therapeutics.
  • MaRS and adMare joined their expertise and resources to support the growth of therapeutics ventures in the MaRS-adMare Accelerator.
  • "MaRS and adMare are excited to support Quthero and their team, in the first cohort of the Therapeutics (Tx) Accelerator, to bring their great science to the market and ultimately to patients.

Latest Updates of Viva's Portfolio Companies

Retrieved on: 
Monday, December 4, 2023
JAK1, NMPA, Patient, American College of Rheumatology, Bayer, SUA, Neoplasm, Cataract, Therapy, URAT1, MBA, Cancer, Health care, Inflammation, Fabry disease, Safety, Toxicity, IND, SHP2, USD, Strong, Letter, Woman, EA Phenomic, Pharmacokinetics, VBI, HER2, MPM, Antibody, GCS, GEJ, Boehringer, Research, Plasma, Boehringer Ingelheim, Clinical trial, Investment, MaRS Discovery District, FDA, American College, Phase II, Clostridial necrotizing enteritis, Selective, MPH, ACR, EGFR, Pharmaceutical industry, Astellas Pharma, Phase, Deka, Facet joint arthrosis

TORONTO & WALTHAM, Mass.--(BUSINESS WIRE)--On Nov. 29th, Phenomic AI ("Phenomic"), invested and incubated by Viva BioInnovator (VBI), announced that they have entered into a strategic collaboration and licensing agreement with Boehringer Ingelheim to discover targets important in stroma-rich cancers. The partners will leverage Phenomic's expertise in target identification and stromal biology based on its scTx® single-cell transcriptomics platform which will greatly enhance Boehringer's efforts to develop first-in-class medicines to transform the lives of people with cancer by delivering meaningful advances with the ultimate goal to cure a range of cancers. Phenomic will receive upfront and near-term payments of approximately $9 million including research funding and collaboration milestones. Phenomic is also eligible to receive more than USD $500 million in licensing fees as well as clinical, regulatory and commercial milestones in addition to royalties on future product sales.

Key Points: 
  • HONG KONG, Dec. 4, 2023 /PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies' long-term development.
  • This continuous innovation keeps companies up to date and promotes the evolution of R&D and the success of commercialization.
  • Recently, Viva's portfolio companies have new updates.
  • Phenomic will receive upfront and near-term payments of approximately $9 million including research funding and collaboration milestones.

bioMérieux Canada, AMMI Canada, EPIC and AMR-One Health Consortium co-host the second Canadian symposium to fight antimicrobial resistance

Retrieved on: 
Wednesday, November 22, 2023
Ministry, EPIC, Global health, Research, Emerging, Microbiology, WHO, OHC, Risk, Disease, One Health, MaRS Discovery District, Infection, Death, Pharmacology, AMR, Diagnosis, Software, Medical microbiology, Veterinary medicine, Physician, Legislation, Public, Education, Ministry of Health, Medical device, Pharmaceutical industry, Health

This scientific summit aims to identify concrete actions to combat antimicrobial resistance while highlighting Canadian research and leadership in this crucial fight.

Key Points: 
  • This scientific summit aims to identify concrete actions to combat antimicrobial resistance while highlighting Canadian research and leadership in this crucial fight.
  • "Infectious Diseases physicians, medical microbiologists and clinical microbiologists are actively involved in research, innovation and education to combat antimicrobial resistance.
  • A One Health approach in line with the Pan-Canadian Action Plan to combat AMR is a priority"," says Dr. Deborah Yamamura, President of AMMI Canada.
  • Several discussions will also focus on the One Health approach, which, with its collaborative cross-disciplinary and cross-sector approach, is essential in the fight against antimicrobial resistance.

Construction Tech Innovator, Brickeye, Completes Significant Investment Round

Retrieved on: 
Tuesday, October 31, 2023
Internet of things, EDC, Insurance, MaRS Discovery District, Construction, Intellectual, Growth, Risk management, Risk, BDC, IP

TORONTO, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Brickeye , a leading construction IoT and data analytics technology company, announces the successful first closing of a $10 million investment round.

Key Points: 
  • TORONTO, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Brickeye , a leading construction IoT and data analytics technology company, announces the successful first closing of a $10 million investment round.
  • Brickeye intends to use the funds for continued growth of its risk mitigation and productivity platform for the construction and insurance industries.
  • Brickeye is transforming how insurance providers place, underwrite, and protect policies by helping insureds de-risk projects in pre-construction and mitigate risk during construction.
  • "This investment round reaffirms our commitment to providing game-changing solutions that reduce risk and drive productivity, ultimately benefiting everyone involved in construction projects."

STEMCELL Technologies Expands into Toronto’s MaRS Centre, Grows North American Presence

Retrieved on: 
Thursday, October 26, 2023
Research, Genetics, Clinical Trials, Biotechnology, Other Health, Health, General Health, Other Science, Science, University Avenue, Heart, Stemcell Technologies, LEED, Scientist, Doctor of Philosophy, University, Multimedia, McCulloch, Sculpture, Film industry, Pharmaceutical industry, MaRS Discovery District, DRS

STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the opening of its new Canadian sales office at the MaRS Centre in downtown Toronto, Ontario.

Key Points: 
  • STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the opening of its new Canadian sales office at the MaRS Centre in downtown Toronto, Ontario.
  • (Photo: Business Wire)
    “The opening of our new Toronto base marks a major milestone in STEMCELL’s 30-year history and is a testament to our growing presence in North America,” said Dr. Allen Eaves, President and CEO, STEMCELL.
  • STEMCELL will take up occupancy at MaRS' West Tower, a LEED Gold building, at 661 University Avenue.
  • Unveiled in 2017, the sculpture was donated to MaRS by STEMCELL and today sits outside the MaRS Centre entrance.

Kids Help Phone (KHP), Elevate and MaRS announce a $2 Million innovation challenge, aimed at reshaping the youth mental health ecosystem, all in support of young people

Retrieved on: 
Wednesday, September 27, 2023
COVID-19, Entrepreneurship, Death, Mental health, Family, Suicide, Request for solution, Elevate, Kids Help Phone, Pharmaceutical industry, Toy, MaRS Discovery District

"Suicide is the second-highest cause of death for youth in Canada," said Katherine Hay, President & CEO of Kids Help Phone.

Key Points: 
  • "Suicide is the second-highest cause of death for youth in Canada," said Katherine Hay, President & CEO of Kids Help Phone.
  • Kids Help Phone has supported young people nearly 16 million times since the onset of COVID-19 — this number increases every day.
  • On average, 75 per cent of young people share something with Kids Help Phone they've never shared with anyone else.
  • On average, 88 per cent of young people feel better after connecting with Kids Help Phone.

MaRS teams up with Elevate to showcase innovators in sustainability and AI at the 2023 Festival

Retrieved on: 
Thursday, September 21, 2023
Design Exchange, Fintech, Business development, Agreeableness, Senior, Food, The arts, Accreditation, St. Lawrence Centre, Meridian Hall, Policy, Advocate, Minerva, Elevate Festival, Producer, Actor, Master class, Marketing, St. Lawrence Centre for the Arts, Organization, Elevate, Climate, Entrepreneurship, AI, SVP, Society, Film industry, Fair, Cryptocurrency, Management, MaRS Discovery District, Opiconsivia, Growth, Clean technology

In 2023, Elevate Festival continues to bring top tech leaders and luminaries to its stages, inspiring an audience of 10,000+ entrepreneurs, investors, startups, media, policy makers and innovators.

Key Points: 
  • In 2023, Elevate Festival continues to bring top tech leaders and luminaries to its stages, inspiring an audience of 10,000+ entrepreneurs, investors, startups, media, policy makers and innovators.
  • "We're thrilled to be working with MaRS to shine a spotlight on Canadian innovators who are tackling some of today's biggest challenges," says Lisa Zarzeczny, Co-Founder and CEO of Elevate.
  • "MaRS is doing incredible work to create opportunities for Canadian startups and scaleups, and we're proud to be working alongside them."
  • Elevate Festival will tackle 11 content tracks this year including AI, future societies, cybersecurity, as well as the latest trends in gaming, fintech, and the future of work.

InnerSpace Closes $10M Series A Funding to Accelerate Growth in PropTech Sector

Retrieved on: 
Thursday, August 10, 2023
IAF, AngelList, Software as a service, Wi-Fi, Education, Workplace, MaRS Discovery District, API, Innerspace, CAD, BDC, BI, SOC, Privacy, Movement, RTLS, Arista, US, SOC 2, GDPR, Juniper, Management

TORONTO, Aug. 10, 2023 /PRNewswire-PRWeb/ -- InnerSpace, the only SaaS-based space utilization platform that leverages existing Wi-Fi infrastructure – without the need of sensors – to deliver actionable insights to optimize work space usage, today announced the completion of its $10M CAD Series A round. Led by Yaletown Partners, with previous round participants including BDC and IAF, the round will accelerate InnerSpace's product development roadmap and scale operations to serve the growing US$45 billion space utilization analytics market.

Key Points: 
  • "Our clients are facing an unprecedented tension between their largest operational expenses - employee productivity and real estate consumption," said James Wu, CEO of InnerSpace.
  • "Never before have CEOs faced a complete overhaul of workstyles and unused real estate on such a massive scale.
  • Clients use InnerSpace data to help them make decisions about their workplaces; whether to contract or expand their footprint, renovate, or reallocate resources.
  • With InnerSpace real estate and workplace experience teams optimize team placement, meeting room needs, and overall square footage requirements.

Government of Canada and FCM support creation of CAANZero, enabling municipalities to advance climate action

Retrieved on: 
Thursday, July 6, 2023
Partnership, FCM, Federation of Canadian Municipalities, Municipality, GHG, Government, Federation, Climate change, Natural Resources, GMF, Local government in Canada, City, Renewable energy, MaRS Discovery District, Mars

To support Canadians in delivering economic opportunities and clean air, the Government of Canada and the Federation of Canadian Municipalities (FCM) are investing in initiatives that will help municipalities reach net-zero from coast-to-coast-to-coast.

Key Points: 
  • To support Canadians in delivering economic opportunities and clean air, the Government of Canada and the Federation of Canadian Municipalities (FCM) are investing in initiatives that will help municipalities reach net-zero from coast-to-coast-to-coast.
  • The Green Municipal Fund (GMF), administered by the Federation of Canadian Municipalities, is funded through an endowment by the Government of Canada.
  • "The Government of Canada is pleased to support the MaRS' Climate Action Accelerator to Net Zero through the Green Municipal Fund.
  • Through CAANZero, municipalities can access the expertise and financial support they currently lack to quickly identify achievable high-impact projects and get them done."